Purdue Pharma就其在类阿片危机中的作用提出74亿美元的解决方案。 Purdue Pharma proposes $7.4 billion settlement for its role in the opioid crisis.

OxyContin的制造者Purdue Pharma提出了74亿美元的解决方案,以解决有关其在类阿片危机中的作用的诉讼。 Purdue Pharma, maker of OxyContin, has proposed a $7.4 billion settlement to address lawsuits over its role in the opioid crisis. 该公司所有者萨克勒家族将在15年内提供高达70亿美元的现金,这是最大的一笔预付付款。 The Sackler family, owners of the company, would contribute up to $7 billion in cash over 15 years, with the largest payment upfront. 这项解决方案如获批准,将向各州、地方政府和受类阿片伤害的个人划拨资金,并包括普鲁杜尔成为一家以打击类阿片成瘾为重点的公益公司的规定。 The settlement, if approved, will allocate funds to states, local governments, and individuals harmed by opioids, and includes provisions for Purdue to become a public benefit company focused on combating opioid addiction. 该计划旨在解决与类阿片流行有关的最大的公司破产问题,自1996年OxyContin启动以来,阿片流行已造成数十万人死亡。 The plan aims to resolve the largest corporate bankruptcy related to the opioid epidemic, which has caused hundreds of thousands of deaths since OxyContin's launch in 1996.